홈 › 유방암 › 텍사스

텍사스의 유방암 임상 시험

유방암 관련 연구 177개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The Methodist Hospital Research Institute, Houston
The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06324357

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

NEXT Dallas, Irving

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07578571

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NEXT Houston, Galveston
NEXT Oncology - PARENT, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07360314

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Houston
Research Site, Round Rock

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

El Paso Texas Oncology, El Paso
Kelsey Seybold Clinic, Houston
University of Texas, Houston
외 2개

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05827081

IKS014 in Advanced Solid Tumors That Express HER2

START Dallas - Fort Worth, Fort Worth

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05872295

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

The University of Texas Md Anderson Cancer Center, Houston
Next Oncology Dallas, Irving
Next Oncology, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06120283

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Dallas

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Texas Oncology - DFW ( Site 8003), Dallas
JPS Health Network ( Site 0067), Fort Worth
Texas Oncology - Gulf Coast ( Site 8006), Houston
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07060807

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Next Oncology Austin, Austin
The University of Texas Md Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07222267

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

The University of Texas M. D. Anderson Cancer Center, Houston

피험자 모집 중

18세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT07179809

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Dallas
Research Site, El Paso
Research Site, Sugar Land

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

University of Texas Southwestern Medical Center, Dallas
Houston Methodist Cancer Center, Houston
The University of Texas M.D. Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07007559

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

M D Anderson Cancer Center, Houston

피험자 모집 중

30세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT02945579

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

M D Anderson Cancer Center, Houston

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05766891

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Texas Oncology-Dallas Presbyterian Hospital ( Site 8000), Dallas
Parkland Health and Hospital System ( Site 0069), Dallas
UT Southwestern Medical Center ( Site 0050), Dallas
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Hendrick Medical Center ( Site 0009), Abilene
Texas Oncology - DFW ( Site 8009), Dallas
UT Southwestern ( Site 0092), Dallas
외 7개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06966700

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

Houston Methodist Hospital, Houston

피험자 모집 중1상

18세 ~ 80세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06251544

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NEXT Oncology - Irving, Irving

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT06618287

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Dallas
Clinical Trial Site, Dallas
Clinical Trial Site, Denton
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Houston Methodist Hospital, Houston

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07214532

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

University of Texas MD Anderson Cancer Center, Houston
Houston Methodist Hospital, Houston
Oncology Consultants P.A., Houston
외 1개

피험자 모집 중2상

18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07287098

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine, Houston
MD Anderson Cancer Clinic - Mays Clinic, Houston

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06085833

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Texas Oncology - DFW (Sammons CC), Dallas
Baylor College of Medicine, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Hendrick Medical Center, Abilene
World Research Link, Baytown
Parkland Health and Hospital System, Dallas
외 10개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Texas Oncology - DFW (Sammons CC), Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07114601

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

South Texas Accelerated Research Therapeutics, LLC (START), San Antonio

피험자 모집 중1상

18세 이상 · 여성 · 2026. 9. 21. 업데이트됨 · NCT07524855

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Renovatio Clinical - El Paso, El Paso
JPS Health Network, Fort Worth
Renovatio Clinical, The Woodlands

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05894239

Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

Baylor Medicine, Houston
MD Anderson Cancer Center, Houston

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT03796559

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Baylor College of Medicine, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07340541

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M D Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT04038619

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

MD Anderson Cancer Center, Houston
START Center for Cancer Research, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

OneR The Center For Cancer And Blood Disorders (Texas Cancer Care), Arlington
OneR The Center For Cancer And Blood Disorders (Texas Cancer Care), Burleson
UT Southwestern Medical Center at Redbird, Dallas
외 9개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07173751

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

Cypress Innovative Breast Care Center, Cypress

피험자 모집 중관찰 연구

18세 ~ 94세 · 여성 · 2026. 9. 17. 업데이트됨 · NCT07505797

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Baylor Scott & White Research Institute -Texas Oncology, Dallas
UT Southwestern Medical Center, Dallas
South Texas Accelerated Research Therapeutics (START), LLC, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06827236

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

New Experimental Therapeutics - NEXT Oncology, Austin
Texas Oncology, Bedford
UT Southwest Simmons Cancer Center, Dallas
외 2개

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04585750

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Hendrick Cancer Center, Abilene
Texas Oncology-Northeast Texas, Allen
Texas Oncology - DFW, Dallas
외 9개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

Md Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06756932

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

M D Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 여성 · 2026. 9. 14. 업데이트됨 · NCT04090567

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.